Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

Pentasialotransferrin

Immunology & Autoimmune

Pentasialo transferrinPenta-TfTransferrin, pentasialo isoform

Review status

Currently under review

Pending specialist review and validation.

What it shows

Pentasialotransferrin is one of the naturally occurring forms of transferrin, the protein that carries iron in your blood. Each transferrin molecule can have different numbers of sialic acid groups attached; the pentasialo form carries five. Laboratories can separate these forms and report each as a percentage of total transferrin.

This test is usually performed as part of a transferrin isoform profile using techniques such as capillary electrophoresis or mass spectrometry. Looking at the balance among the isoforms helps clinicians understand how well your body is attaching sugar chains to proteins, a process called glycosylation.

Why it matters

Your pattern of transferrin isoforms can change when glycosylation is altered. This can happen in inherited conditions known as congenital disorders of glycosylation, and it can also occur with liver disease, chronic inflammation, or significant alcohol use. The pentasialo fraction is one piece of that broader pattern and helps refine interpretation when the overall profile looks unusual.

Clinicians may order this measurement if you have symptoms that raise concern for a glycosylation disorder, if your carbohydrate-deficient transferrin test needs clarification, or if there is suspected liver injury. Tracking the isoform pattern can also help monitor recovery or the impact of treating an underlying cause.

Understanding your results

Results are reported as the percentage of pentasialotransferrin relative to all transferrin isoforms. A result higher or lower than expected is interpreted together with the other isoforms, your medical history, examination findings, and other lab tests. A single value rarely provides a diagnosis on its own.

If your result falls outside the expected pattern, your clinician may suggest repeat testing, additional liver and inflammation markers, review of alcohol intake and medications, or specialized testing for congenital disorders of glycosylation. Most follow-up steps are tailored to your situation and are discussed with you before further decisions are made.

Reference ranges

12.932.4 %
All sexes
0 days – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact Pentasialotransferrin

  • Recent alcohol use

    Sustained or heavy drinking can shift the transferrin isoform pattern and may indirectly change the pentasialo fraction. Let your clinician know about alcohol intake so results can be interpreted correctly.

  • Liver health

    Liver diseases such as hepatitis, cirrhosis, or cholestasis can alter protein glycosylation and affect the distribution of transferrin isoforms, including pentasialotransferrin.

  • Genetic glycosylation disorders

    Congenital disorders of glycosylation can markedly change the balance of transferrin isoforms. Abnormal patterns may prompt targeted genetic and metabolic evaluation.

  • Pregnancy and estrogen exposure

    Pregnancy and estrogen-containing therapies can influence transferrin production and glycosylation, potentially shifting the observed isoform percentages.

  • Medications and inflammation

    Some antiepileptics, hormones, and chronic inflammatory states can modify glycosylation pathways and impact isoform distribution. Share a full medication list with your care team.

  • Sample handling

    Improper storage, hemolysis, or delayed processing can compromise isoform separation and quantification. Laboratories follow strict procedures to minimize these effects.

2026

References

  1. McGill University Health Centre. (2012, December 13). Pentasialotransferrin (Task CD 10236566). Laboratory reference ranges.
  2. Wopereis, S., Grünewald, S., Morava, E., Penzien, J. M., Wevers, R. A., & Lefeber, D. J. (2007). Transferrin isoform analysis by capillary electrophoresis in the diagnosis of congenital disorders of glycosylation. Clinical Chemistry and Laboratory Medicine, 45(9), 1270–1276.
  3. Helander, A., & Weykamp, C. (2010). Standardization and use of carbohydrate-deficient transferrin as a biomarker of alcohol consumption: Recommendations from the IFCC Working Group on CDT. Clinica Chimica Acta, 411(21–22), 1599–1605.
  4. Lefeber, D. J., Morava, E., & Jaeken, J. (2011). How to find and diagnose a congenital disorder of glycosylation. Journal of Inherited Metabolic Disease, 34(4), 849–852.